Skip to main content

Table 4 Measured test substance deposition in the lung, expected deposition calculated by the Multiple Path Particle Dosimetry (MPPD) model, measured (absolute and relative) decrease of lung burden (clearance) after the recovery period

From: Application of short-term inhalation studies to assess the inhalation toxicity of nanomaterials

Test substance

Assumed 100% deposition (mg)

(Lung burden) Measured test material on study day 5 (μg/lung)

Measured deposition (%)

Calculated deposition (%)

Measured lung burden after recovery period (μg/lung)

% Decrease of lung burden after recovery perioda

Coated nano-TiO 2 (T-lite SFâ„¢ containing 82% TiO 2 and 10% Al(OH) 3 )

3.85

459.0 ± 71.3 (TiO2) 49.1 ± 7.6 (Al(OH)3)

12.4%b

19.1%

467.4 ± 43.4 (TiO2) 46.3 ± 5.0 (Al(OH)3)

+1%

Micron-scale ZnO

5.508

82.3 ± 12.5

1.5%

10.3%

27.1 ± 1.5

n.a.

Coated nano-ZnO (NM-111)

0.216

33.9 ± 7.0

15.7%

12.4%

25.4 ± 1.3

n.a.

1.008

123.4 ± 28.4

12.2%

13.5%

26.3 ± 1.5

n.a.

4.968

428.2 ± 19.4

8.6%

13.4%

28.4 ± 4.1

n.a.

SiO 2 .naked

18.936

342.3 ± 10.7

1.8%

5.1%

208.2 ± 16.1

−39%

SiO 2 .acrylate

0.216

18.6 ± 6.2

8.6%

7.1%

15.7 ± 6.9

−16%

0.756

37.1 ± 6.9

4.9%

7.9%

30.0 ± 7.7

−19%

3.492

200.0 ± 30.9

5.7%

6.8%

132.1 ± 43.3

−34%

SiO 2 .PEG

0.738

59.2 ± 11.0

8.0%

8.8%

25.7 ± 2.1

−57%

3.60

182.6 ± 27.1

5.1%

8.8%

117.0 ± 45.7

−36%

19.476

834.3 ± 206.3

4.3%

6.5%

370.8 ± 40.5

−56%

SiO 2 .phosphate

1.044

71.3 ± 11.0

6.8%

10.9%

47.8 ± 3.3

−33%

3.60

194.7 ± 11.9

5.4%

6.1%

104.8 ± 21.4

−46%

18.54

499.2 ± 30.9

2.7%

6.2%

303.8 ± 91.1

−39%

SiO 2 .amino

0.756

87.0 ± 14.2

11.5%

10.5%

52.1 ± 9.6

−41%

3.672

295.9 ± 81.7

8.1%

5.3%

154.7 ± 25.7

−48%

18.144

741.6 ± 157.7

4.1%

5.4%

474.2 ± 155.1

- 36%

Nano-BaSO 4 (NM-220) c

19.224

1055.7

5.5%

9.6%

239.7

−77%

Nano-ZrO 2

0.18

18.0 ± 5.6

10.0%

7.3%

6.8 ± 3.6

−62%

0.936

20.3d 117.5

2.2% 12.6%

8.2%

29.3 ± 6.2

−75%

3.456

270.6 ± 28.9

7.8%

6.7%

157.6 ± 19.0

−42%

ZrO 2 .TODA

0.720

83.3 ± 6.4

11.6%

10.9%

41.9 ± 5.4

−50%

3.816

233.2 ± 6.9

6.1%

10.9%

87.3 ± 62.8

−63%

18.792

693.4 ± 121.8

3.7%

7.7%

520.5 ± 82.0

- 25%

ZrO 2 .acrylate

0.684

7e

1.0%

16.0%

LOQ

 

3.636

70

1.9%

11.1%

49

- 30%

18.18

169

0.9%

7.7%

190

+ 12%

Nano-scale CeO 2

0.277

52.0 ± 5.0

18.8%

16.6%

44.2 ± 4.4

−15%

1.069

165.8 ± 18.4

15.5%

14.3%

157.6 ± 18.7

−5%

4.176

417.6 ± 44.3

10.0%

15.4%

470.9 ± 51.2

+13%

Al-doped nano-scale CeO 2 c

3.312

326.8

7.8%

6.8%

304.7

−7%

  1. n.a.: Not applicable: Zn content returned to control levels in all concentration groups. No relative decrease of lung burden was calculated due to high endogenous content of Zn.
  2. LOQ: limit of quantification.
  3. aRecovery period for SiO2.acrylate was 14 days after the final exposure. For all other substances, the recovery period was 21 days.
  4. bTotal amount of TiO2 and Al(OH)3 was assumed as total deposition.
  5. cOnly one rat was examined.
  6. dOnly two samples were examined which differed considerably and hence are presented as individual animal data.
  7. eData for one animal, LOQ in the other two.